Literature DB >> 11076705

HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections.

J May1, B Lell, A J Luty, C G Meyer, P G Kremsner.   

Abstract

Protective immunity against Plasmodium falciparum requires constant exposure to the pathogen. T cell-mediated immune responses are induced by T cell epitopes of pre-erythrocytic stage antigens of P. falciparum and involve HLA-restricted CD4 and CD8 cells. Cytotoxic T cell responses to a conserved epitope of P. falciparum liver stage antigen (LSA) type 1 are restricted by the HLA class I allele Bw53. The role of HLA class II alleles in mediating cellular responses against P. falciparum LSA-1 has not yet been demonstrated. In a longitudinal study performed for >4 years, associations were found between the HLA class II allele DQB1*0501 and protection from malaria anemia and malarial reinfections in Gabonese children. Children carrying DQB1*0501 had a higher frequency of interferon-gamma responses to LSA-1 T cell epitopes, compared with noncarriers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076705     DOI: 10.1086/317642

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.

Authors:  Magdalena Plebanski; Owen Proudfoot; Dodie Pouniotis; Ross L Coppel; Vasso Apostolopoulos; Graham Flannery
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

2.  Role of the HLA-DQ locus in the development of chronic gastritis and gastric carcinoma in Mexican patients.

Authors:  Roberto Herrera-Goepfert; Jesus-K Yamamoto-Furusho; Luis-F Onate-Ocana; Margarita Camorlinga-Ponce; Leopoldo Munoz; Jorge-A Ruiz-Morales; Gilberto Vargas-Alarcon; Julio Granados
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  An engineered Plasmodium falciparum C-terminal 19-kilodalton merozoite surface protein 1 vaccine candidate induces high levels of interferon-gamma production associated with cellular immune responses to specific peptide sequences in Gambian adults naturally exposed to malaria.

Authors:  C Bisseye; L M Yindom; J Simporé; W D Morgan; A A Holder; J Ismaili
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

4.  Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity.

Authors:  Cong Han; Yahui Lin; Guangliang Shan; Zaixing Zhang; Xiaodong Sun; Zhensheng Wang; Chunyan Wei; Yan Deng; Lianhui Zhang; Lingyi Bu; Dingding Shao; Heng Wang
Journal:  Clin Vaccine Immunol       Date:  2010-08-11

5.  Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.

Authors:  Clara Brando; Lisa A Ware; Helen Freyberger; April Kathcart; Arnoldo Barbosa; Sylvie Cayphas; Marie-Ange Demoitie; Pascal Mettens; D Gray Heppner; David E Lanar
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

6.  Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.

Authors:  Chandy C John; Ann M Moormann; Peter O Sumba; Ayub V Ofulla; Daniel C Pregibon; James W Kazura
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I.

Authors:  Simone Jüliger; Martina Bongartz; Adrian J F Luty; Peter G Kremsner; Jürgen F J Kun
Journal:  Immunogenetics       Date:  2002-12-14       Impact factor: 2.846

Review 8.  Immunity to liver stage malaria: considerations for vaccine design.

Authors:  Andrew W Taylor-Robinson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

9.  Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase.

Authors:  William S Nicoll; John B Sacci; Carlo Rodolfo; Giuseppina Di Giacomo; Mauro Piacentini; Zoe Jm Holland; Christian Doerig; Michael R Hollingdale; David E Lanar
Journal:  Malar J       Date:  2011-01-21       Impact factor: 2.979

10.  Complement receptor 1 and the molecular pathogenesis of malaria.

Authors:  Monika Gandhi
Journal:  Indian J Hum Genet       Date:  2007-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.